New RNA injection could help hearts heal after heart attacks

by admin | Mar 27, 2026 | News & Opinions

By Drug Target Review – A new RNA-based therapy developed at Columbia University could help the heart repair itself after a heart attack without invasive surgery. After a heart attack, it is possible for cardiologists to reopen blocked vessels and restart blood...

Japan Approves the World’s First Treatment Made With Reprogrammed Human Cells

by admin | Mar 26, 2026 | News & Opinions

By Ritsuko Kawa – Wired – Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology. On March 6, Japan’s Ministry of Health,...

With FDA go ahead, a China biotech notches a first in cell therapy testing

by admin | Mar 25, 2026 | News & Opinions

by Jacob Bell – BioPharmaDive – The agency has now cleared Shanghai-based Unixell to begin human studies in the U.S. for an allogeneic, stem cell-derived therapy targeting focal epilepsy. For the first time, the Food and Drug Administration is allowing a...

FDA must regulate stem cell therapies to mitigate risks to patients and the public

by admin | Mar 24, 2026 | News & Opinions

By PNAS.org – In December 2025, the US Food and Drug Administration’s (FDA’s) Center for Biologics Evaluation and Review (CBER) approved a gene-based stem cell therapy for Wiskott–Aldrich syndrome, a rare and life-threatening genetic disease. This decision was...

Gene-based therapies poised for major upgrade thanks to Oregon State University research

by admin | Mar 23, 2026 | News & Opinions

By Steve Lundeberg – Oregon State University – by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells. Findings of the study spearheaded by Oregon State University College of Pharmacy graduate...